FMP
Evolutionary Genomics, Inc.
FNAM
OTC
Inactive Equity
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
0.45 USD
-0.15 (-33.33%)
About
ceo
Mr. Steve B. Warnecke
sector
Healthcare
industry
Biotechnology
website
https://www.evolgen.com
exchange
OTC
Description
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
CIK
0000884363
ISIN
US30051F1012
CUSIP
30051F101
Address
1026 Anaconda Drive
Phone
720 900 8666
Country
US
Employee
2
IPO Date
May 15, 2012
Summary
CIK
0000884363
Exchange
OTC
Industry
Biotechnology
Sector
Healthcare
CUSIP
30051F101
ISIN
US30051F1012
Country
US
Price
0.45
Beta
-0.36
Volume Avg.
416
Market Cap
2.99M
Shares
-
52-Week
0.45-0.72
DCF
1.04
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.29
P/B
-
Website
https://www.evolgen.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest FNAM News
It looks like there's no news available.
